Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Gross Profit (2020 - 2025)

Agilon Health (AGL) has disclosed Gross Profit for 6 consecutive years, with $1.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 20.1% year-over-year to $1.7 billion, compared with a TTM value of $5.9 billion through Dec 2025, up 7.96%, and an annual FY2025 reading of $5.9 billion, up 1.34% over the prior year.
  • Gross Profit was $1.7 billion for Q4 2025 at Agilon Health, up from $1.4 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $1.7 billion in Q4 2025 and bottomed at $10.5 million in Q4 2021.
  • Average Gross Profit over 5 years is $876.9 million, with a median of $899.0 million recorded in 2023.
  • The sharpest move saw Gross Profit crashed 62.48% in 2021, then skyrocketed 7251.11% in 2022.
  • Year by year, Gross Profit stood at $10.5 million in 2021, then surged by 7251.11% to $774.4 million in 2022, then fell by 0.13% to $773.4 million in 2023, then skyrocketed by 78.55% to $1.4 billion in 2024, then rose by 20.1% to $1.7 billion in 2025.
  • Business Quant data shows Gross Profit for AGL at $1.7 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.3 billion in Q2 2025.